The effect of eplerenone on the renin-angiotensin-aldosterone system of rats with thyroid dysfunction [PDF]
, 2019 Kawa Dizaye, Zana Ahmed Mustafa
openalex +1 more source
Eplerenone Crystal Nanosuspension for Solubility Enhancement: Preparation and Evaluation
, 2023 Hawraa k. Khafeef, Nawal A. Rajab
openalex +1 more source
Missed opportunities: low use of evidence-based treatment with eplerenone after myocardial infarction - a nationwide study [PDF]
, 2013 Siv Mari Berger +7 more
openalex +1 more source
Эплеренон в лечении хронической болезни почек при сопутствующей артериальной гипертензии [PDF]
, 2014 Литературный обзор посвящен месту селективных блокаторов альдостерона в лечении хронической болезни почек при сопутствующей артериальной ...
Авдеева, И. В. +3 more
core +1 more source
B004 Effects of the selective mineralocorticoid receptor antagonist, eplerenone, in a model of aldosterone-induced hypertension and cardiac fibrosis [PDF]
, 1998 Gregory E. Frierdich
openalex +1 more source
Remote results of using aldosterone antagonists in complex treatment of patients with myocardial infarction and heart failure [PDF]
, 2015 The work presents remote results of using aldosterone in complex treatment of patients with myocardial infarction combined with heart failure. It is shown that after using of eplerenone the authenticity of renewal functional indexes of myocardium becomes
Gulaga, O.I. +3 more
core
56 The impact of statin therapy on the efficacy of eplerenone [PDF]
, 2005 Harvey D. White +6 more
openalex +1 more source
#4590 A PROSPECTIVE STUDY OF EPLERENONE IN THE TREATMENT OF PATIENTS WITH GLOMERULONEPHRITIS [PDF]
, 2023 Marios Papasotiriou +5 more
openalex +1 more source
Тривале спостереження за хворими на гострий інфаркт міокарда при використанні антагоністів альдостерону [PDF]
, 2013 Проведено аналіз віддалених результатів використання антагоністів альдостерону (спіронолактону та еплеренону) у комплексному лікуванні хворих на інфаркт міокарда з серцевою недостатністю.
Гулага, Ольга Ігорівна +2 more
core
Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity [PDF]
, 2017 Received 22 July 2012; revised 29 January 2013; accepted 4 March 2013Aims Aldosterone plays a crucial role in cardiovascular disease. ‘Systemic' inhibition of its mineralocorticoid receptor (MR) decreases atherosclerosis by reducing inflammation and ...
Berger, Stefan +11 more
core